Our Network AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases Tags: #Cell therapy #Oncology #Autoimmune Diseases #CART #AstraZeneca Includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and proprietary cell therapy manufacturing platform.
